Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis: the PRAIRI study

Danielle M. Gerlag, Mary Safy, Karen I. Maijer, Man Wai Tang, Sander W. Tas, Mirian J. F. Starmans-Kool, Astrid van Tubergen, Matthijs Janssen, Maria de Hair, Monika Hansson, Niek de Vries, Aeilko H. Zwinderman, Paul P. Tak*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)179-185
Number of pages7
JournalAnnals of the Rheumatic Diseases
Volume78
Issue number2
DOIs
Publication statusPublished - Feb 2019

Keywords

  • SEROPOSITIVE ARTHRALGIA
  • TARGETED THERAPY
  • RISK-FACTORS
  • DISEASE
  • RITUXIMAB
  • AUTOANTIBODIES
  • METHOTREXATE
  • INDIVIDUALS
  • INDUCTION
  • EFFICACY

Cite this

Gerlag, D. M., Safy, M., Maijer, K. I., Tang, M. W., Tas, S. W., Starmans-Kool, M. J. F., ... Tak, P. P. (2019). Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis: the PRAIRI study. Annals of the Rheumatic Diseases, 78(2), 179-185. https://doi.org/10.1136/annrheumdis-2017-212763
Gerlag, Danielle M. ; Safy, Mary ; Maijer, Karen I. ; Tang, Man Wai ; Tas, Sander W. ; Starmans-Kool, Mirian J. F. ; van Tubergen, Astrid ; Janssen, Matthijs ; de Hair, Maria ; Hansson, Monika ; de Vries, Niek ; Zwinderman, Aeilko H. ; Tak, Paul P. / Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis : the PRAIRI study. In: Annals of the Rheumatic Diseases. 2019 ; Vol. 78, No. 2. pp. 179-185.
@article{072300998c924121a545fdfb46bc8886,
title = "Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis: the PRAIRI study",
keywords = "SEROPOSITIVE ARTHRALGIA, TARGETED THERAPY, RISK-FACTORS, DISEASE, RITUXIMAB, AUTOANTIBODIES, METHOTREXATE, INDIVIDUALS, INDUCTION, EFFICACY",
author = "Gerlag, {Danielle M.} and Mary Safy and Maijer, {Karen I.} and Tang, {Man Wai} and Tas, {Sander W.} and Starmans-Kool, {Mirian J. F.} and {van Tubergen}, Astrid and Matthijs Janssen and {de Hair}, Maria and Monika Hansson and {de Vries}, Niek and Zwinderman, {Aeilko H.} and Tak, {Paul P.}",
year = "2019",
month = "2",
doi = "10.1136/annrheumdis-2017-212763",
language = "English",
volume = "78",
pages = "179--185",
journal = "Annals of the Rheumatic Diseases",
issn = "0003-4967",
publisher = "BMJ Publishing Group",
number = "2",

}

Gerlag, DM, Safy, M, Maijer, KI, Tang, MW, Tas, SW, Starmans-Kool, MJF, van Tubergen, A, Janssen, M, de Hair, M, Hansson, M, de Vries, N, Zwinderman, AH & Tak, PP 2019, 'Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis: the PRAIRI study', Annals of the Rheumatic Diseases, vol. 78, no. 2, pp. 179-185. https://doi.org/10.1136/annrheumdis-2017-212763

Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis : the PRAIRI study. / Gerlag, Danielle M.; Safy, Mary; Maijer, Karen I.; Tang, Man Wai; Tas, Sander W.; Starmans-Kool, Mirian J. F.; van Tubergen, Astrid; Janssen, Matthijs; de Hair, Maria; Hansson, Monika; de Vries, Niek; Zwinderman, Aeilko H.; Tak, Paul P.

In: Annals of the Rheumatic Diseases, Vol. 78, No. 2, 02.2019, p. 179-185.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis

T2 - the PRAIRI study

AU - Gerlag, Danielle M.

AU - Safy, Mary

AU - Maijer, Karen I.

AU - Tang, Man Wai

AU - Tas, Sander W.

AU - Starmans-Kool, Mirian J. F.

AU - van Tubergen, Astrid

AU - Janssen, Matthijs

AU - de Hair, Maria

AU - Hansson, Monika

AU - de Vries, Niek

AU - Zwinderman, Aeilko H.

AU - Tak, Paul P.

PY - 2019/2

Y1 - 2019/2

KW - SEROPOSITIVE ARTHRALGIA

KW - TARGETED THERAPY

KW - RISK-FACTORS

KW - DISEASE

KW - RITUXIMAB

KW - AUTOANTIBODIES

KW - METHOTREXATE

KW - INDIVIDUALS

KW - INDUCTION

KW - EFFICACY

U2 - 10.1136/annrheumdis-2017-212763

DO - 10.1136/annrheumdis-2017-212763

M3 - Article

VL - 78

SP - 179

EP - 185

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - 2

ER -